Combined SHP2 and MEK inhibition is effective in models of NF1-deficient malignant peripheral nerve sheath tumors. (October 2020) - Wang, J.; Pollard, K.; Allen, A.; Tomar, T.; Pijnenburg, D.; Yao, Z.; Rodriguez, F.; Pratilas, C.